Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory
Clinical Genetics · 2024
DOI: 10.1111/cge.14593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2024. Verfasst von Tonje Talsnes Stava und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Cardiac and Cardiovascular Genetics, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Genetic Testing, Arrhythmias, Cardiac. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: South-Eastern Norway Regional Health Authority, Helse Sør-Øst RHF.
Abstract (Originalsprache)
The aim of this study was to explore the prevalence of likely pathogenic or pathogenic variants and assess the diagnostic yield from genetic testing for cardiac arrhythmias in Norway since 2003. Data from 1991 probands and 2782 relatives were retrospectively collected from the laboratory information management system at Unit for Cardiac and Cardiovascular Genetics, Oslo University hospital. Of 1991 probands, 57.4% were females, age at genetic testing was 33.1 (±22.7) years, and 32.5% were under the age of 18. A likely pathogenic or pathogenic variant (including 14 novel) was detected in 15.4% in total. Of the 2782 relatives, 53.7% were females, age at genetic testing was 35.6 (±22.5) years, 27.3% were under the age of 18, and 45.3% carried the family variant. Probands and relatives combined, 1/3356 persons in the Norwegian population were heterozygous for an arrhythmia‐causing variant. The founder variant p.Q530X (NM_000218.2: c.1588C>T) in KCNQ1 accounted for 34% of all variants in Norway. In conclusion, genetic testing provided a genetic basis of the arrhythmia in 15.4% of the probands. Familial cascade screening identified four times as many variant‐positive relatives, allowing early detection and prompt stratification of arrhythmic risk of those variant carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit for Cardiac and Cardiovascular Genetics, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
- ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Paediatric Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Förderung
- South-Eastern Norway Regional Health Authority
- Helse Sør-Øst RHF
Zitieren
APA
Stava, T. T., Berge, K. E., Haugaa, K. H., Smedsrud, M. K., Leren, T. P., & Bogsrud, M. P. (2024). Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory. Clinical Genetics. https://doi.org/10.1111/cge.14593
Vancouver
Stava TT, Berge KE, Haugaa KH, Smedsrud MK, Leren TP, Bogsrud MP. Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory. Clinical Genetics. 2024. doi:10.1111/cge.14593
BibTeX
@article{Stava2024,
author = {Stava, Tonje Talsnes and Berge, Knut Erik and Haugaa, Kristina Hermann and Smedsrud, Marit Kristine and Leren, Trond P and Bogsrud, Martin Prøven},
title = {Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory},
journal = {Clinical Genetics},
year = {2024},
doi = {10.1111/cge.14593}
}
EUVIMED